context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 3392000 | monetaryItemType | text: <entity> 3392000 </entity> <entity type> monetaryItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. | text | 3284000 | monetaryItemType | text: <entity> 3284000 </entity> <entity type> monetaryItemType </entity type> <context> Under the Company's Employee Savings Plan, a defined contribution plan, all U.S. employees who have attained age 21 may contribute up to 100 % of their pay on a pre-tax basis under the Company's Employee Savings Plan, subject to the annual dollar limitations established by the Internal Revenue Service ("IRS"). The Company matches 50 % of the first 6 % of pay an employee contributes. Company contributions vest 25 %, 50 %, 75 %, and 100 % after one, two, three, and four years of continuous employment with the Company, respectively. Company contributions totaled $ 3,535,000 in 2024, $ 3,392,000 in 2023, and $ 3,284,000 in 2022. Cognex stock is not an investment alternative and Company contributions are not made in the form of Cognex stock. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 35253000 | monetaryItemType | text: <entity> 35253000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 16039000 | monetaryItemType | text: <entity> 16039000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 48546000 | monetaryItemType | text: <entity> 48546000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 96236000 | monetaryItemType | text: <entity> 96236000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 119309000 | monetaryItemType | text: <entity> 119309000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign |
Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. | text | 202149000 | monetaryItemType | text: <entity> 202149000 </entity> <entity type> monetaryItemType </entity type> <context> Domestic income before taxes was $ 35,253,000 in 2024, $ 16,039,000 in 2023, and $ 48,546,000 in 2022. Foreign income before taxes was $ 96,236,000 in 2024, $ 119,309,000 in 2023, and $ 202,149,000 in 2022. </context> | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign |
The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. | text | 4997000 | monetaryItemType | text: <entity> 4997000 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. | text | 3339000 | monetaryItemType | text: <entity> 3339000 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s reserve for income taxes, including gross interest and penalties, was $ 28,733,000 as of December 31, 2024, of which $ 26,365,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The Company's reserve for income taxes, including gross interest and penalties, was $ 29,053,000 as of December 31, 2023, of which $ 26,685,000 was classified as a non-current liability and $ 2,368,000 was classified as an offset to deferred tax assets. The amount of gross interest and penalties included in these balances was $ 4,997,000 and $ 3,339,000 as of December 31, 2024 and 2023, respectively. If the Company’s tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $ 2,000,000 to $ 4,000,000 over the next twelve months. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 12.5 | percentItemType | text: <entity> 12.5 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 25 | percentItemType | text: <entity> 25 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 34.6 | percentItemType | text: <entity> 34.6 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 21 | percentItemType | text: <entity> 21 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 4 | percentItemType | text: <entity> 4 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 6 | percentItemType | text: <entity> 6 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 7 | percentItemType | text: <entity> 7 </entity> <entity type> percentItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential |
The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. | text | 1400000 | monetaryItemType | text: <entity> 1400000 </entity> <entity type> monetaryItemType </entity type> <context> The Company has defined its major tax jurisdictions as the United States, Ireland, China, Japan, and Korea and within the United States, Massachusetts. The statutory tax rate is 12.5 % in Ireland, 25 % in China, 34.6 % in Japan, and 21 % in Korea, compared to the U.S. federal statutory corporate tax rate of 21 %. These differences resulted in a favorable impact to the effective tax rate of 4 percentage points for 2024, 6 percentage points for 2023, and 7 percentage points for 2022. Management has determined that earnings from its legal entities in China will be indefinitely reinvested to provide local funding for growth, and that earnings from all other jurisdictions will not be indefinitely reinvested. In 2024, the Company recorded a non-current deferred tax liability of $ 1,400,000 with respect to earnings that are not indefinitely reinvested. In 2023, the Company qualified for a tax holiday in China, which is renewed every three years. The tax effect of this benefit on basic and diluted earnings per share for 2024 was not material. </context> | us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings |
Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. | text | 2145000 | monetaryItemType | text: <entity> 2145000 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. | text | 1032000 | monetaryItemType | text: <entity> 1032000 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. | text | 229000 | monetaryItemType | text: <entity> 229000 </entity> <entity type> monetaryItemType </entity type> <context> Interest and penalties included in income tax expense were $ 2,145,000 in 2024, $ 1,032,000 in 2023, and $ 229,000 in 2022. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense |
Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. | text | 59849000 | monetaryItemType | text: <entity> 59849000 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. </context> | us-gaap:IncomeTaxesPaidNet |
Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. | text | 56618000 | monetaryItemType | text: <entity> 56618000 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. </context> | us-gaap:IncomeTaxesPaidNet |
Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. | text | 57016000 | monetaryItemType | text: <entity> 57016000 </entity> <entity type> monetaryItemType </entity type> <context> Cash paid for income taxes totaled $ 59,849,000 in 2024, $ 56,618,000 in 2023, and $ 57,016,000 in 2022. </context> | us-gaap:IncomeTaxesPaidNet |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 1306000 | monetaryItemType | text: <entity> 1306000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 2567000 | monetaryItemType | text: <entity> 2567000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 1720000 | monetaryItemType | text: <entity> 1720000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign |
As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . | text | 943000 | monetaryItemType | text: <entity> 943000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had foreign net operating loss carryforwards of $ 1,306,000 , state tax credit carryforwards of $ 7,619,000 that will begin to expire for the 2031 tax return, and foreign tax credit carryforwards of $ 2,567,000 . As of December 31, 2023, the Company had foreign net operating loss carryforwards of $ 1,720,000 , state tax credit carryforwards of $ 8,740,000 , and foreign tax credit carryforwards of $ 943,000 . </context> | us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign |
As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these | text | 599000 | monetaryItemType | text: <entity> 599000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these | text | 1916000 | monetaryItemType | text: <entity> 1916000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these | text | 943000 | monetaryItemType | text: <entity> 943000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had a valuation allowance for foreign net operation loss carryforwards of $ 599,000 and a valuation allowance for foreign tax credits of $ 1,916,000 that were not considered to be realized. As of December 31, 2023, the Company had a valuation allowance for foreign tax credits of $ 943,000 that was not considered to be realized. Should these credits be utilized in a future period, the reserve associated with these </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 8496599 | sharesItemType | text: <entity> 8496599 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 6854092 | sharesItemType | text: <entity> 6854092 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 4715104 | sharesItemType | text: <entity> 4715104 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 365 | sharesItemType | text: <entity> 365 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | 26079 | sharesItemType | text: <entity> 26079 </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. | text | No | sharesItemType | text: <entity> No </entity> <entity type> sharesItemType </entity type> <context> Stock options to purchase 8,496,599 , 6,854,092 , and 4,715,104 shares of common stock, on a weighted-average basis, were outstanding in 2024, 2023, and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. Restricted stock units totaling 365 and 26,079 that will be settled in shares of common stock to the extent they vest, on a weighted-average basis, were outstanding in 2023 and 2022, respectively, but were not included in the calculation of dilutive net income per share because they were anti-dilutive. No restricted stock units were excluded in the calculation of dilutive net income per share in 2024. No PRSUs were excluded in the calculation of dilutive net income per share in 2024, 2023, and 2022 as PRSUs were not anti-dilutive on a weighted-average basis. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
The Company operates in one segment, machine vision technology. The Company has a single, company-wide management team that administers operations as a whole rather than as discrete operating segments. The Company’s chief operating decision maker is the chief executive officer, who assesses performance and allocates resources at the corporate level, as compared to the geography, product line, or end market levels. The Company offers a variety of machine vision products that have similar economic characteristics and are distributed by the same sales channels to the same types of customers. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> The Company operates in one segment, machine vision technology. The Company has a single, company-wide management team that administers operations as a whole rather than as discrete operating segments. The Company’s chief operating decision maker is the chief executive officer, who assesses performance and allocates resources at the corporate level, as compared to the geography, product line, or end market levels. The Company offers a variety of machine vision products that have similar economic characteristics and are distributed by the same sales channels to the same types of customers. </context> | us-gaap:NumberOfReportableSegments |
Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> Revenue from a single customer accounted for 10 % and 11 % of total revenue in 2024 and 2022, respectively. Revenue from this customer was not greater than 10% of total revenue in 2023. Accounts receivable from this customer was 10 % of total accounts receivable as of December 31, 2024 and was not greater than 10% of total accounts receivable as of December 31, 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
Revenue from a second customer accounted for 11 % of total revenue in 2022. Revenue from this customer was not greater than 10% of total revenue in 2024 or 2023. Accounts receivable from this customer was not greater than 10% of total accounts receivable as of December 31, 2024 or December 31, 2023. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> Revenue from a second customer accounted for 11 % of total revenue in 2022. Revenue from this customer was not greater than 10% of total revenue in 2024 or 2023. Accounts receivable from this customer was not greater than 10% of total accounts receivable as of December 31, 2024 or December 31, 2023. </context> | us-gaap:ConcentrationRiskPercentage1 |
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. | text | 12524000 | monetaryItemType | text: <entity> 12524000 </entity> <entity type> monetaryItemType </entity type> <context> (1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. </context> | us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization |
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. | text | 7065000 | monetaryItemType | text: <entity> 7065000 </entity> <entity type> monetaryItemType </entity type> <context> (1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. </context> | us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization |
(1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. | text | 6270000 | monetaryItemType | text: <entity> 6270000 </entity> <entity type> monetaryItemType </entity type> <context> (1) Cost of revenue includes depreciation and amortization expense (including amortization of acquired technologies) of $ 12,524,000 , $ 7,065,000 , and $ 6,270,000 for 2024, 2023, and 2022, respectively. </context> | us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 44376245000 | monetaryItemType | text: <entity> 44376245000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 296138000 | monetaryItemType | text: <entity> 296138000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 44227414000 | monetaryItemType | text: <entity> 44227414000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 295144000 | monetaryItemType | text: <entity> 295144000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 148831000 | monetaryItemType | text: <entity> 148831000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 994000 | monetaryItemType | text: <entity> 994000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 38088000 | monetaryItemType | text: <entity> 38088000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents |
The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. | text | 257056000 | monetaryItemType | text: <entity> 257056000 </entity> <entity type> monetaryItemType </entity type> <context> The cash-free, debt-free enterprise value was adjusted by cash acquired, debt assumed, and final working capital balances to arrive at total consideration to be allocated to assets acquired and liabilities assumed of ¥ 44,376,245,000 ($ 296,138,000 based on the closing date foreign exchange rate), of which ¥ 44,227,414,000 ($ 295,144,000 ) was paid in cash on the closing date and ¥ 148,831,000 ($ 994,000 ) was paid during the first quarter of 2024 as a purchase price adjustment based on the closing balance sheet. The Company acquired cash balances totaling $ 38,088,000 as part of this transaction, to arrive at a net cash outflow of $ 257,056,000 on the closing date. There was no contingent consideration as part of this transaction. </context> | us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired |
In the fourth quarter of 2024, the Company recorded measurement-period adjustments that increased goodwill by $ 6,478,000 and are reflected in the final purchase price allocation below. The adjustments consisted primarily of changes to deferred income tax liabilities based on the final push-down accounting for intangible assets to legal-entity jurisdictions, a reduction in customer relationships based on a methodology refinement, and changes to provisional assets and liabilities based on new information obtained within the one-year measurement period that refined initial estimates. | text | 6478000 | monetaryItemType | text: <entity> 6478000 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2024, the Company recorded measurement-period adjustments that increased goodwill by $ 6,478,000 and are reflected in the final purchase price allocation below. The adjustments consisted primarily of changes to deferred income tax liabilities based on the final push-down accounting for intangible assets to legal-entity jurisdictions, a reduction in customer relationships based on a methodology refinement, and changes to provisional assets and liabilities based on new information obtained within the one-year measurement period that refined initial estimates. </context> | us-gaap:GoodwillPurchaseAccountingAdjustments |
Transaction costs were approximately $ 5,800,000 and were expensed as incurred as part of SG&A expenses on the Consolidated Statement of Operations. | text | 5800000 | monetaryItemType | text: <entity> 5800000 </entity> <entity type> monetaryItemType </entity type> <context> Transaction costs were approximately $ 5,800,000 and were expensed as incurred as part of SG&A expenses on the Consolidated Statement of Operations. </context> | us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts |
On February 12, 2025, the Company's Board of Directors declared a cash dividend of $ 0.080 per share. The dividend is payable March 13, 2025 to all shareholders of record as of the close of business on February 27, 2025. | text | 0.080 | perShareItemType | text: <entity> 0.080 </entity> <entity type> perShareItemType </entity type> <context> On February 12, 2025, the Company's Board of Directors declared a cash dividend of $ 0.080 per share. The dividend is payable March 13, 2025 to all shareholders of record as of the close of business on February 27, 2025. </context> | us-gaap:DividendsPayableAmountPerShare |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 26 | percentItemType | text: <entity> 26 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 24 | percentItemType | text: <entity> 24 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 28 | percentItemType | text: <entity> 28 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 15 | percentItemType | text: <entity> 15 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 21 | percentItemType | text: <entity> 21 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 18 | percentItemType | text: <entity> 18 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. | text | 16 | percentItemType | text: <entity> 16 </entity> <entity type> percentItemType </entity type> <context> We market and sell our products through both our direct sales force and our channel partners, including distributors, value-added resellers, system integrators and OEM partners, and in conjunction with various technology partners. Significant customers are those that represent more than 10% of our total net revenue during the period or net accounts receivable balance at each respective balance sheet date. As of December 31, 2024, we had two resellers who represented 26 % and 24 % of total accounts receivable. As of December 31, 2023, we had two resellers who represented 28 % and 11 % of total accounts receivable. There were two end customers who represented more than 10% of our total revenue for the years ended 2024, 2023 and 2022. Sales to one end customer represented 15 %, 21 % and 26 % of our total revenue, and sales to the other end customer represented 20 %, 18 % and 16 % of our total revenue for the years ended 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
Inventories primarily consist of finished goods, including evaluation inventory held at customers or partners, and strategic components, primarily integrated circuits. Inventories are stated at the lower of cost (computed using the first-in, first-out method) and net realizable value. Evaluation inventory consists of new products and/or use cases at customer or partner sites for trial purposes. Title to the inventory remains with Arista during the trial period and invoicing occurs only upon completion of the trial period and when/if the products have been accepted by the customer. Manufacturing overhead costs and inbound shipping costs are included in the cost of inventory. We record a provision when inventory is determined to be in excess of anticipated demand, or obsolete, to adjust inventory to its estimated realizable value. For the years ended December 31, 2024, 2023 and 2022, we recorded charges of $ 267.2 million, $ 234.4 million and $ 71.4 million, respectively, within cost of product revenue for inventory write-downs. | text | 267.2 | monetaryItemType | text: <entity> 267.2 </entity> <entity type> monetaryItemType </entity type> <context> Inventories primarily consist of finished goods, including evaluation inventory held at customers or partners, and strategic components, primarily integrated circuits. Inventories are stated at the lower of cost (computed using the first-in, first-out method) and net realizable value. Evaluation inventory consists of new products and/or use cases at customer or partner sites for trial purposes. Title to the inventory remains with Arista during the trial period and invoicing occurs only upon completion of the trial period and when/if the products have been accepted by the customer. Manufacturing overhead costs and inbound shipping costs are included in the cost of inventory. We record a provision when inventory is determined to be in excess of anticipated demand, or obsolete, to adjust inventory to its estimated realizable value. For the years ended December 31, 2024, 2023 and 2022, we recorded charges of $ 267.2 million, $ 234.4 million and $ 71.4 million, respectively, within cost of product revenue for inventory write-downs. </context> | us-gaap:InventoryWriteDown |
Inventories primarily consist of finished goods, including evaluation inventory held at customers or partners, and strategic components, primarily integrated circuits. Inventories are stated at the lower of cost (computed using the first-in, first-out method) and net realizable value. Evaluation inventory consists of new products and/or use cases at customer or partner sites for trial purposes. Title to the inventory remains with Arista during the trial period and invoicing occurs only upon completion of the trial period and when/if the products have been accepted by the customer. Manufacturing overhead costs and inbound shipping costs are included in the cost of inventory. We record a provision when inventory is determined to be in excess of anticipated demand, or obsolete, to adjust inventory to its estimated realizable value. For the years ended December 31, 2024, 2023 and 2022, we recorded charges of $ 267.2 million, $ 234.4 million and $ 71.4 million, respectively, within cost of product revenue for inventory write-downs. | text | 234.4 | monetaryItemType | text: <entity> 234.4 </entity> <entity type> monetaryItemType </entity type> <context> Inventories primarily consist of finished goods, including evaluation inventory held at customers or partners, and strategic components, primarily integrated circuits. Inventories are stated at the lower of cost (computed using the first-in, first-out method) and net realizable value. Evaluation inventory consists of new products and/or use cases at customer or partner sites for trial purposes. Title to the inventory remains with Arista during the trial period and invoicing occurs only upon completion of the trial period and when/if the products have been accepted by the customer. Manufacturing overhead costs and inbound shipping costs are included in the cost of inventory. We record a provision when inventory is determined to be in excess of anticipated demand, or obsolete, to adjust inventory to its estimated realizable value. For the years ended December 31, 2024, 2023 and 2022, we recorded charges of $ 267.2 million, $ 234.4 million and $ 71.4 million, respectively, within cost of product revenue for inventory write-downs. </context> | us-gaap:InventoryWriteDown |
Inventories primarily consist of finished goods, including evaluation inventory held at customers or partners, and strategic components, primarily integrated circuits. Inventories are stated at the lower of cost (computed using the first-in, first-out method) and net realizable value. Evaluation inventory consists of new products and/or use cases at customer or partner sites for trial purposes. Title to the inventory remains with Arista during the trial period and invoicing occurs only upon completion of the trial period and when/if the products have been accepted by the customer. Manufacturing overhead costs and inbound shipping costs are included in the cost of inventory. We record a provision when inventory is determined to be in excess of anticipated demand, or obsolete, to adjust inventory to its estimated realizable value. For the years ended December 31, 2024, 2023 and 2022, we recorded charges of $ 267.2 million, $ 234.4 million and $ 71.4 million, respectively, within cost of product revenue for inventory write-downs. | text | 71.4 | monetaryItemType | text: <entity> 71.4 </entity> <entity type> monetaryItemType </entity type> <context> Inventories primarily consist of finished goods, including evaluation inventory held at customers or partners, and strategic components, primarily integrated circuits. Inventories are stated at the lower of cost (computed using the first-in, first-out method) and net realizable value. Evaluation inventory consists of new products and/or use cases at customer or partner sites for trial purposes. Title to the inventory remains with Arista during the trial period and invoicing occurs only upon completion of the trial period and when/if the products have been accepted by the customer. Manufacturing overhead costs and inbound shipping costs are included in the cost of inventory. We record a provision when inventory is determined to be in excess of anticipated demand, or obsolete, to adjust inventory to its estimated realizable value. For the years ended December 31, 2024, 2023 and 2022, we recorded charges of $ 267.2 million, $ 234.4 million and $ 71.4 million, respectively, within cost of product revenue for inventory write-downs. </context> | us-gaap:InventoryWriteDown |
Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. The Company has one reporting unit and tests goodwill for impairment at least annually in the fourth quarter or more frequently if indicators of potential impairment exist. We first perform a qualitative assessment to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If the reporting unit does not pass the qualitative assessment, a quantitative test is performed by comparing the fair value of our reporting unit with its carrying amount. We would recognize an impairment loss for the amount by which the carrying amount exceeds the fair value. There were no impairment charges in any of the periods presented in the consolidated financial statements. See Note 4. Acquisition, Goodwill and Acquisition-Related Intangible Assets for additional information. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. The Company has one reporting unit and tests goodwill for impairment at least annually in the fourth quarter or more frequently if indicators of potential impairment exist. We first perform a qualitative assessment to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If the reporting unit does not pass the qualitative assessment, a quantitative test is performed by comparing the fair value of our reporting unit with its carrying amount. We would recognize an impairment loss for the amount by which the carrying amount exceeds the fair value. There were no impairment charges in any of the periods presented in the consolidated financial statements. See Note 4. Acquisition, Goodwill and Acquisition-Related Intangible Assets for additional information. </context> | us-gaap:NumberOfReportingUnits |
(1) The balance as of December 31, 2024 includes evaluation inventory held at customers or partners of $ 422.1 million. Evaluation inventory as of December 31, 2023 was no t material. | text | 422.1 | monetaryItemType | text: <entity> 422.1 </entity> <entity type> monetaryItemType </entity type> <context> (1) The balance as of December 31, 2024 includes evaluation inventory held at customers or partners of $ 422.1 million. Evaluation inventory as of December 31, 2023 was no t material. </context> | us-gaap:InventoryFinishedGoodsNetOfReserves |
(1) The balance as of December 31, 2024 includes evaluation inventory held at customers or partners of $ 422.1 million. Evaluation inventory as of December 31, 2023 was no t material. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> (1) The balance as of December 31, 2024 includes evaluation inventory held at customers or partners of $ 422.1 million. Evaluation inventory as of December 31, 2023 was no t material. </context> | us-gaap:InventoryFinishedGoodsNetOfReserves |
Depreciation expense was $ 34.0 million, $ 31.7 million and $ 25.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 34.0 | monetaryItemType | text: <entity> 34.0 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 34.0 million, $ 31.7 million and $ 25.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense was $ 34.0 million, $ 31.7 million and $ 25.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 31.7 | monetaryItemType | text: <entity> 31.7 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 34.0 million, $ 31.7 million and $ 25.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
Depreciation expense was $ 34.0 million, $ 31.7 million and $ 25.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 25.6 | monetaryItemType | text: <entity> 25.6 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense was $ 34.0 million, $ 31.7 million and $ 25.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
Other performance obligations totaling $ 450.4 million as of December 31, 2024 include unbilled multi-year PCS and service contract amounts of $ 388.8 million and $ 61.6 million of binding contractual agreements with certain customers that are primarily related to future product shipments. | text | 450.4 | monetaryItemType | text: <entity> 450.4 </entity> <entity type> monetaryItemType </entity type> <context> Other performance obligations totaling $ 450.4 million as of December 31, 2024 include unbilled multi-year PCS and service contract amounts of $ 388.8 million and $ 61.6 million of binding contractual agreements with certain customers that are primarily related to future product shipments. </context> | us-gaap:RevenueRemainingPerformanceObligation |
Other performance obligations totaling $ 450.4 million as of December 31, 2024 include unbilled multi-year PCS and service contract amounts of $ 388.8 million and $ 61.6 million of binding contractual agreements with certain customers that are primarily related to future product shipments. | text | 388.8 | monetaryItemType | text: <entity> 388.8 </entity> <entity type> monetaryItemType </entity type> <context> Other performance obligations totaling $ 450.4 million as of December 31, 2024 include unbilled multi-year PCS and service contract amounts of $ 388.8 million and $ 61.6 million of binding contractual agreements with certain customers that are primarily related to future product shipments. </context> | us-gaap:RevenueRemainingPerformanceObligation |
Other performance obligations totaling $ 450.4 million as of December 31, 2024 include unbilled multi-year PCS and service contract amounts of $ 388.8 million and $ 61.6 million of binding contractual agreements with certain customers that are primarily related to future product shipments. | text | 61.6 | monetaryItemType | text: <entity> 61.6 </entity> <entity type> monetaryItemType </entity type> <context> Other performance obligations totaling $ 450.4 million as of December 31, 2024 include unbilled multi-year PCS and service contract amounts of $ 388.8 million and $ 61.6 million of binding contractual agreements with certain customers that are primarily related to future product shipments. </context> | us-gaap:RevenueRemainingPerformanceObligation |
Total revenue from our contract liabilities, deferred revenue and other performance obligations that is expected to be recognized in future periods was $ 3.4 billion as of December 31, 2024. Approximately 85 % of this future revenue is expected to be recognized over the next two years and the remaining 15 % is expected to be recognized during the third to the fifth year. | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> Total revenue from our contract liabilities, deferred revenue and other performance obligations that is expected to be recognized in future periods was $ 3.4 billion as of December 31, 2024. Approximately 85 % of this future revenue is expected to be recognized over the next two years and the remaining 15 % is expected to be recognized during the third to the fifth year. </context> | us-gaap:RevenueRemainingPerformanceObligationPercentage |
Total revenue from our contract liabilities, deferred revenue and other performance obligations that is expected to be recognized in future periods was $ 3.4 billion as of December 31, 2024. Approximately 85 % of this future revenue is expected to be recognized over the next two years and the remaining 15 % is expected to be recognized during the third to the fifth year. | text | 15 | percentItemType | text: <entity> 15 </entity> <entity type> percentItemType </entity type> <context> Total revenue from our contract liabilities, deferred revenue and other performance obligations that is expected to be recognized in future periods was $ 3.4 billion as of December 31, 2024. Approximately 85 % of this future revenue is expected to be recognized over the next two years and the remaining 15 % is expected to be recognized during the third to the fifth year. </context> | us-gaap:RevenueRemainingPerformanceObligationPercentage |
Amortization expense related to acquisition-related intangible assets was $ 26.8 million, $ 33.4 million and $ 33.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 26.8 | monetaryItemType | text: <entity> 26.8 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to acquisition-related intangible assets was $ 26.8 million, $ 33.4 million and $ 33.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to acquisition-related intangible assets was $ 26.8 million, $ 33.4 million and $ 33.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 33.4 | monetaryItemType | text: <entity> 33.4 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to acquisition-related intangible assets was $ 26.8 million, $ 33.4 million and $ 33.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense related to acquisition-related intangible assets was $ 26.8 million, $ 33.4 million and $ 33.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 33.7 | monetaryItemType | text: <entity> 33.7 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense related to acquisition-related intangible assets was $ 26.8 million, $ 33.4 million and $ 33.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
We outsource most of our manufacturing and supply chain management operations to third-party contract manufacturers, who procure components and assemble products on our behalf. A significant portion of our purchase orders to our contract manufacturers for finished products consists of non-cancellable purchase commitments. In addition, we purchase strategic component inventory from certain suppliers under non-cancellable purchase commitments, including integrated circuits, which are consigned to our contract manufacturers. As of December 31, 2024, we had non-cancellable purchase commitments not recorded on our balance sheet of $ 3.1 billion, of wh | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> We outsource most of our manufacturing and supply chain management operations to third-party contract manufacturers, who procure components and assemble products on our behalf. A significant portion of our purchase orders to our contract manufacturers for finished products consists of non-cancellable purchase commitments. In addition, we purchase strategic component inventory from certain suppliers under non-cancellable purchase commitments, including integrated circuits, which are consigned to our contract manufacturers. As of December 31, 2024, we had non-cancellable purchase commitments not recorded on our balance sheet of $ 3.1 billion, of wh </context> | us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted |
ich $ 2.8 billion have confirmed receipt dates | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> ich $ 2.8 billion have confirmed receipt dates </context> | us-gaap:PurchaseObligationDueInNextTwelveMonths |
On November 25, 2020, WSOU Investments LLC ("WSOU") filed a lawsuit against us in the Western District of Texas asserting that certain of our products infringe three WSOU patents. WSOU's allegations are directed to certain features of our wireless and switching products. WSOU seeks remedies including monetary damages, attorney's fees and costs. On February 4, 2021, we filed an answer denying WSOU's allegations. On November 5, 2021, the case was transferred to the Northern District of California. On March 30, 2022, WSOU dismissed one of the patents with prejudice, removing Arista wireless products from those accused of infringement. On July 1, 2022, the court stayed the case pending the resolution of an | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> On November 25, 2020, WSOU Investments LLC ("WSOU") filed a lawsuit against us in the Western District of Texas asserting that certain of our products infringe three WSOU patents. WSOU's allegations are directed to certain features of our wireless and switching products. WSOU seeks remedies including monetary damages, attorney's fees and costs. On February 4, 2021, we filed an answer denying WSOU's allegations. On November 5, 2021, the case was transferred to the Northern District of California. On March 30, 2022, WSOU dismissed one of the patents with prejudice, removing Arista wireless products from those accused of infringement. On July 1, 2022, the court stayed the case pending the resolution of an </context> | us-gaap:LossContingencyPatentsAllegedlyInfringedNumber |
On November 25, 2020, WSOU Investments LLC ("WSOU") filed a lawsuit against us in the Western District of Texas asserting that certain of our products infringe three WSOU patents. WSOU's allegations are directed to certain features of our wireless and switching products. WSOU seeks remedies including monetary damages, attorney's fees and costs. On February 4, 2021, we filed an answer denying WSOU's allegations. On November 5, 2021, the case was transferred to the Northern District of California. On March 30, 2022, WSOU dismissed one of the patents with prejudice, removing Arista wireless products from those accused of infringement. On July 1, 2022, the court stayed the case pending the resolution of an | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> On November 25, 2020, WSOU Investments LLC ("WSOU") filed a lawsuit against us in the Western District of Texas asserting that certain of our products infringe three WSOU patents. WSOU's allegations are directed to certain features of our wireless and switching products. WSOU seeks remedies including monetary damages, attorney's fees and costs. On February 4, 2021, we filed an answer denying WSOU's allegations. On November 5, 2021, the case was transferred to the Northern District of California. On March 30, 2022, WSOU dismissed one of the patents with prejudice, removing Arista wireless products from those accused of infringement. On July 1, 2022, the court stayed the case pending the resolution of an </context> | us-gaap:LossContingencyPatentsFoundNotInfringedNumber |
In April 2024, we completed repurchases under our previous $ 1.0 billion stock repurchase program (the “Prior Repurchase Program”). In May 2024, our board of directors authorized a new $ 1.2 billion stock repurchase program (the “New Repurchase Program” and together with the Prior Repurchase Program, the "Repurchase Programs"), which expires in May 2027. This authorization allows us to repurchase shares of our common stock that will be funded from working capital. Repurchases may be made at management's discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or a combination of the foregoing. The Repurchase Programs do not obligate us to acquire any of our common stock, and may be suspended or discontinued by the company at any time without prior notice. During the year ended December 31, 2024, we repurchased a total of $ 279.0 million of our common stock under our New Repurchase Program and $ 144.6 million of our common stock under our Prior Repurchase Program. As of December 31, 2024, the remaining authorized amount for stock repurchases under the New Repurchase Program was approximately $ 921.0 million. | text | 279.0 | monetaryItemType | text: <entity> 279.0 </entity> <entity type> monetaryItemType </entity type> <context> In April 2024, we completed repurchases under our previous $ 1.0 billion stock repurchase program (the “Prior Repurchase Program”). In May 2024, our board of directors authorized a new $ 1.2 billion stock repurchase program (the “New Repurchase Program” and together with the Prior Repurchase Program, the "Repurchase Programs"), which expires in May 2027. This authorization allows us to repurchase shares of our common stock that will be funded from working capital. Repurchases may be made at management's discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or a combination of the foregoing. The Repurchase Programs do not obligate us to acquire any of our common stock, and may be suspended or discontinued by the company at any time without prior notice. During the year ended December 31, 2024, we repurchased a total of $ 279.0 million of our common stock under our New Repurchase Program and $ 144.6 million of our common stock under our Prior Repurchase Program. As of December 31, 2024, the remaining authorized amount for stock repurchases under the New Repurchase Program was approximately $ 921.0 million. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
In April 2024, we completed repurchases under our previous $ 1.0 billion stock repurchase program (the “Prior Repurchase Program”). In May 2024, our board of directors authorized a new $ 1.2 billion stock repurchase program (the “New Repurchase Program” and together with the Prior Repurchase Program, the "Repurchase Programs"), which expires in May 2027. This authorization allows us to repurchase shares of our common stock that will be funded from working capital. Repurchases may be made at management's discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or a combination of the foregoing. The Repurchase Programs do not obligate us to acquire any of our common stock, and may be suspended or discontinued by the company at any time without prior notice. During the year ended December 31, 2024, we repurchased a total of $ 279.0 million of our common stock under our New Repurchase Program and $ 144.6 million of our common stock under our Prior Repurchase Program. As of December 31, 2024, the remaining authorized amount for stock repurchases under the New Repurchase Program was approximately $ 921.0 million. | text | 144.6 | monetaryItemType | text: <entity> 144.6 </entity> <entity type> monetaryItemType </entity type> <context> In April 2024, we completed repurchases under our previous $ 1.0 billion stock repurchase program (the “Prior Repurchase Program”). In May 2024, our board of directors authorized a new $ 1.2 billion stock repurchase program (the “New Repurchase Program” and together with the Prior Repurchase Program, the "Repurchase Programs"), which expires in May 2027. This authorization allows us to repurchase shares of our common stock that will be funded from working capital. Repurchases may be made at management's discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or a combination of the foregoing. The Repurchase Programs do not obligate us to acquire any of our common stock, and may be suspended or discontinued by the company at any time without prior notice. During the year ended December 31, 2024, we repurchased a total of $ 279.0 million of our common stock under our New Repurchase Program and $ 144.6 million of our common stock under our Prior Repurchase Program. As of December 31, 2024, the remaining authorized amount for stock repurchases under the New Repurchase Program was approximately $ 921.0 million. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
In April 2024, we completed repurchases under our previous $ 1.0 billion stock repurchase program (the “Prior Repurchase Program”). In May 2024, our board of directors authorized a new $ 1.2 billion stock repurchase program (the “New Repurchase Program” and together with the Prior Repurchase Program, the "Repurchase Programs"), which expires in May 2027. This authorization allows us to repurchase shares of our common stock that will be funded from working capital. Repurchases may be made at management's discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or a combination of the foregoing. The Repurchase Programs do not obligate us to acquire any of our common stock, and may be suspended or discontinued by the company at any time without prior notice. During the year ended December 31, 2024, we repurchased a total of $ 279.0 million of our common stock under our New Repurchase Program and $ 144.6 million of our common stock under our Prior Repurchase Program. As of December 31, 2024, the remaining authorized amount for stock repurchases under the New Repurchase Program was approximately $ 921.0 million. | text | 921.0 | monetaryItemType | text: <entity> 921.0 </entity> <entity type> monetaryItemType </entity type> <context> In April 2024, we completed repurchases under our previous $ 1.0 billion stock repurchase program (the “Prior Repurchase Program”). In May 2024, our board of directors authorized a new $ 1.2 billion stock repurchase program (the “New Repurchase Program” and together with the Prior Repurchase Program, the "Repurchase Programs"), which expires in May 2027. This authorization allows us to repurchase shares of our common stock that will be funded from working capital. Repurchases may be made at management's discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or a combination of the foregoing. The Repurchase Programs do not obligate us to acquire any of our common stock, and may be suspended or discontinued by the company at any time without prior notice. During the year ended December 31, 2024, we repurchased a total of $ 279.0 million of our common stock under our New Repurchase Program and $ 144.6 million of our common stock under our Prior Repurchase Program. As of December 31, 2024, the remaining authorized amount for stock repurchases under the New Repurchase Program was approximately $ 921.0 million. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
The Restated Plan provides for the grant of equity-based awards, including stock options, restricted stock units, restricted stock, stock appreciation rights, and performance awards. The share pool available under the prior version of the Company's 2014 Equity Incentive Plan ("Prior Plan") was extinguished, and the Restated Plan provides for a new share pool not to exceed (i) 52,800,000 shares of our Common Stock (“Shares”), plus (ii) any Shares subject to awards under the Prior Plan that, on or after the Effective Date, expired or otherwise terminated without having been exercised in full, or that were forfeited to or repurchased by us, including net settlement of Shares subject to restricted stock units, with the maximum number of Shares to be added to the Restated Plan as a result of clause (ii) equal to 40,158,628 Shares. The Restated Plan’s terms are substantially similar to the Prior Plan’s terms, including with respect to treatment of equity awards in the event of a “change in control” as defined under the Restated Plan, but with certain modifications, including the elimination of the automatic “evergreen” share reserve increase provided for under the Prior Plan. As of December 31, 2024, there remained approximately 52.4 million shares available for grant under the Restated Plan, as adjusted to give effect to the Stock Split. | text | 40158628 | sharesItemType | text: <entity> 40158628 </entity> <entity type> sharesItemType </entity type> <context> The Restated Plan provides for the grant of equity-based awards, including stock options, restricted stock units, restricted stock, stock appreciation rights, and performance awards. The share pool available under the prior version of the Company's 2014 Equity Incentive Plan ("Prior Plan") was extinguished, and the Restated Plan provides for a new share pool not to exceed (i) 52,800,000 shares of our Common Stock (“Shares”), plus (ii) any Shares subject to awards under the Prior Plan that, on or after the Effective Date, expired or otherwise terminated without having been exercised in full, or that were forfeited to or repurchased by us, including net settlement of Shares subject to restricted stock units, with the maximum number of Shares to be added to the Restated Plan as a result of clause (ii) equal to 40,158,628 Shares. The Restated Plan’s terms are substantially similar to the Prior Plan’s terms, including with respect to treatment of equity awards in the event of a “change in control” as defined under the Restated Plan, but with certain modifications, including the elimination of the automatic “evergreen” share reserve increase provided for under the Prior Plan. As of December 31, 2024, there remained approximately 52.4 million shares available for grant under the Restated Plan, as adjusted to give effect to the Stock Split. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Restated Plan provides for the grant of equity-based awards, including stock options, restricted stock units, restricted stock, stock appreciation rights, and performance awards. The share pool available under the prior version of the Company's 2014 Equity Incentive Plan ("Prior Plan") was extinguished, and the Restated Plan provides for a new share pool not to exceed (i) 52,800,000 shares of our Common Stock (“Shares”), plus (ii) any Shares subject to awards under the Prior Plan that, on or after the Effective Date, expired or otherwise terminated without having been exercised in full, or that were forfeited to or repurchased by us, including net settlement of Shares subject to restricted stock units, with the maximum number of Shares to be added to the Restated Plan as a result of clause (ii) equal to 40,158,628 Shares. The Restated Plan’s terms are substantially similar to the Prior Plan’s terms, including with respect to treatment of equity awards in the event of a “change in control” as defined under the Restated Plan, but with certain modifications, including the elimination of the automatic “evergreen” share reserve increase provided for under the Prior Plan. As of December 31, 2024, there remained approximately 52.4 million shares available for grant under the Restated Plan, as adjusted to give effect to the Stock Split. | text | 52.4 | sharesItemType | text: <entity> 52.4 </entity> <entity type> sharesItemType </entity type> <context> The Restated Plan provides for the grant of equity-based awards, including stock options, restricted stock units, restricted stock, stock appreciation rights, and performance awards. The share pool available under the prior version of the Company's 2014 Equity Incentive Plan ("Prior Plan") was extinguished, and the Restated Plan provides for a new share pool not to exceed (i) 52,800,000 shares of our Common Stock (“Shares”), plus (ii) any Shares subject to awards under the Prior Plan that, on or after the Effective Date, expired or otherwise terminated without having been exercised in full, or that were forfeited to or repurchased by us, including net settlement of Shares subject to restricted stock units, with the maximum number of Shares to be added to the Restated Plan as a result of clause (ii) equal to 40,158,628 Shares. The Restated Plan’s terms are substantially similar to the Prior Plan’s terms, including with respect to treatment of equity awards in the event of a “change in control” as defined under the Restated Plan, but with certain modifications, including the elimination of the automatic “evergreen” share reserve increase provided for under the Prior Plan. As of December 31, 2024, there remained approximately 52.4 million shares available for grant under the Restated Plan, as adjusted to give effect to the Stock Split. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
In April 2014, the board of directors and stockholders approved the 2014 Employee Stock Purchase Plan (“ESPP”). The ESPP became effective on the first day that our common stock was publicly traded. The number of shares reserved for issuance under the ESPP increases automatically on January 1 of each year by the number of shares equal to 1 % of our shares outstanding immediately preceding December 31, but not to exceed 40 million shares, unless the board of directors, in its discretion, determines to make a smaller increase. Effective January 1, 2024, our board of directors authorized an increase of 12.5 million shares, as adjusted to give effect to the Stock Split, for future issuance under the ESPP. As of December 31, 2024, there remained 104.9 million shares available for issuance under the ESPP. | text | 12.5 | sharesItemType | text: <entity> 12.5 </entity> <entity type> sharesItemType </entity type> <context> In April 2014, the board of directors and stockholders approved the 2014 Employee Stock Purchase Plan (“ESPP”). The ESPP became effective on the first day that our common stock was publicly traded. The number of shares reserved for issuance under the ESPP increases automatically on January 1 of each year by the number of shares equal to 1 % of our shares outstanding immediately preceding December 31, but not to exceed 40 million shares, unless the board of directors, in its discretion, determines to make a smaller increase. Effective January 1, 2024, our board of directors authorized an increase of 12.5 million shares, as adjusted to give effect to the Stock Split, for future issuance under the ESPP. As of December 31, 2024, there remained 104.9 million shares available for issuance under the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized |
In April 2014, the board of directors and stockholders approved the 2014 Employee Stock Purchase Plan (“ESPP”). The ESPP became effective on the first day that our common stock was publicly traded. The number of shares reserved for issuance under the ESPP increases automatically on January 1 of each year by the number of shares equal to 1 % of our shares outstanding immediately preceding December 31, but not to exceed 40 million shares, unless the board of directors, in its discretion, determines to make a smaller increase. Effective January 1, 2024, our board of directors authorized an increase of 12.5 million shares, as adjusted to give effect to the Stock Split, for future issuance under the ESPP. As of December 31, 2024, there remained 104.9 million shares available for issuance under the ESPP. | text | 104.9 | sharesItemType | text: <entity> 104.9 </entity> <entity type> sharesItemType </entity type> <context> In April 2014, the board of directors and stockholders approved the 2014 Employee Stock Purchase Plan (“ESPP”). The ESPP became effective on the first day that our common stock was publicly traded. The number of shares reserved for issuance under the ESPP increases automatically on January 1 of each year by the number of shares equal to 1 % of our shares outstanding immediately preceding December 31, but not to exceed 40 million shares, unless the board of directors, in its discretion, determines to make a smaller increase. Effective January 1, 2024, our board of directors authorized an increase of 12.5 million shares, as adjusted to give effect to the Stock Split, for future issuance under the ESPP. As of December 31, 2024, there remained 104.9 million shares available for issuance under the ESPP. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
Under our ESPP, eligible employees are permitted to acquire shares of our common stock at 85 % of the lower of the fair market value of our common stock on the first trading day of each offering period or on the exercise date. Each offering period lasts approximately two years starting on the first trading date after February 15 and August 15 of each year, and includes purchase dates every six months on or after February 15 and August 15 of each year. Participants may purchase shares | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees are permitted to acquire shares of our common stock at 85 % of the lower of the fair market value of our common stock on the first trading day of each offering period or on the exercise date. Each offering period lasts approximately two years starting on the first trading date after February 15 and August 15 of each year, and includes purchase dates every six months on or after February 15 and August 15 of each year. Participants may purchase shares </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent |
During the year ended December 31, 2024, we issued 1.12 million shares at an average purchase price of $ 29.08 per share under our ESPP, as adjusted to give effect to the Stock Split. | text | 1.12 | sharesItemType | text: <entity> 1.12 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, we issued 1.12 million shares at an average purchase price of $ 29.08 per share under our ESPP, as adjusted to give effect to the Stock Split. </context> | us-gaap:CommonStockSharesIssued |
During the year ended December 31, 2024, we issued 1.12 million shares at an average purchase price of $ 29.08 per share under our ESPP, as adjusted to give effect to the Stock Split. | text | 29.08 | perShareItemType | text: <entity> 29.08 </entity> <entity type> perShareItemType </entity type> <context> During the year ended December 31, 2024, we issued 1.12 million shares at an average purchase price of $ 29.08 per share under our ESPP, as adjusted to give effect to the Stock Split. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. | text | 495.1 | monetaryItemType | text: <entity> 495.1 </entity> <entity type> monetaryItemType </entity type> <context> We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. | text | 525.3 | monetaryItemType | text: <entity> 525.3 </entity> <entity type> monetaryItemType </entity type> <context> We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. | text | 311.7 | monetaryItemType | text: <entity> 311.7 </entity> <entity type> monetaryItemType </entity type> <context> We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. | text | 5.6 | monetaryItemType | text: <entity> 5.6 </entity> <entity type> monetaryItemType </entity type> <context> We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. | text | 8.7 | monetaryItemType | text: <entity> 8.7 </entity> <entity type> monetaryItemType </entity type> <context> We did not grant any stock options during the years ended December 31, 2024, 2023 and 2022. The aggregate intrinsic value of options exercised during the years ended December 31, 2024, 2023 and 2022 was $ 495.1 million, $ 525.3 million and $ 311.7 million, respectively. The total fair value of options vested for the years ended December 31, 2024, 2023 and 2022 was approximately $ 5.6 million, $ 8.7 million and $ 16.6 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.